UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

Nature medicine, 2020-09, Vol.26 (9), p.1468-1479

2020

Volltextzugriff (PDF)

CK2β-regulated signaling controls B cell differentiation and function

Frontiers in immunology, 2023-01, Vol.13, p.959138-959138

2023

Volltextzugriff (PDF)

CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death

Current cancer drug targets, 2018-01, Vol.18 (6), p.608

2018

Volltextzugriff (PDF)

Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth

Oncotarget, 2015-03, Vol.6 (9), p.6544-6552

2015

Volltextzugriff (PDF)

CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis

HemaSphere, 2023-12, Vol.7 (12), p.e978-n/a

2023

Volltextzugriff (PDF)

T028: Single‐cell RNA sequencing reveals the interplay between circulating CD4 T cells, B cells and cancer‐associated monocytes in classic Hodgkin lymphoma treated with PD‐1 blockade

HemaSphere, 2022-10, Vol.6 (Suppl), p.14-14

2022

Volltextzugriff (PDF)

Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL

Blood, 2019-01, Vol.133 (1), p.70-80

2019

Volltextzugriff (PDF)

MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8

Blood, 2023-10, Vol.142 (14), p.1219

2023

Volltextzugriff (PDF)

MYD88 L265P Augments Proximal B-Cell Receptor Signaling in Large B-Cell Lymphomas Via an Interaction with DOCK8

Blood, 2021-11, Vol.138 (Supplement 1), p.1324-1324

2021

Volltextzugriff (PDF)

Genetic Perturbation of CD70/CD27 Co-Stimulation Promotes the Development of Bcl6-Driven Diffuse Large B-Cell Lymphoma

Blood, 2021-11, Vol.138 (Supplement 1), p.713-713

2021

Volltextzugriff (PDF)

Targeted Inhibition of PI3K α/δ Is Synergistic with BCL-2 Blockade in Genetically Defined Subtypes of DLBCL

Blood, 2018-11, Vol.132 (Supplement 1), p.39-39

2018

Volltextzugriff (PDF)

TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence

Science translational medicine, 2023-09, Vol.15 (714), p.eadi7244

2023

Volltextzugriff (PDF)

CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis

HemaSphere, 2023-12, Vol.7 (12), p.e978-n/a

2023

Volltextzugriff (PDF)

Csnk2β Knockout during Hematopoiesis Results in Lethality at Mid/Late Gestation Mostly Due to Impaired Fetal Erythropoiesis

Blood, 2014-12, Vol.124 (21), p.4329-4329

2014

Volltextzugriff (PDF)

Csnk2β, the Regulatory Subunit of Protein Kinase CK2, modulates Peripheral B Cell Development Repressing Notch2 Signaling and Promoting a Proper B-Cell Receptor Signal Transmission

Blood, 2014-12, Vol.124 (21), p.566-566

2014

Volltextzugriff (PDF)

Protein kinase CK2 regulates peripheral B cell development

Frontiers in immunology, 2013, Vol.4

2013

Volltextzugriff (PDF)

Protein Kinase CK2 Inhibition Down Modulates the NF- Kappa B and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells: e75280

PloS one, 2013-09, Vol.8 (9)

2013

Volltextzugriff (PDF)

Perceived social support and quality of life in endometrial cancer patients: a longitudinal study

Frontiers in oncology, 2024-08, Vol.14, p.1447644

2024

Volltextzugriff (PDF)

Cerebellar metastasis of ovarian cancer: a case report

Journal of medical case reports, 2023-12, Vol.17 (1), p.553-553, Article 553

2023

Volltextzugriff (PDF)

Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review

Journal of pediatric gastroenterology and nutrition, 2021-10, Vol.73 (4), p.444-454

2021

Volltextzugriff (PDF)

Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation

Orphanet journal of rare diseases, 2018-01, Vol.13 (1), p.4-4, Article 4

2018

Volltextzugriff (PDF)

Liver Involvement in Congenital Disorders of Glycosylation

Journal of pediatric gastroenterology and nutrition, 2021-10, Vol.73 (4), p.444-454

2021

Volltextzugriff (PDF)

Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature

Diagnostics (Basel), 2021-01, Vol.11 (2), p.199

2021

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Humans
(12)
Oncology
(7)
Ovarian Cancer
(7)
Apoptosis
(5)
Female
(5)
Animals
(4)
Hematology
(4)
Lymphoma
(4)
Lymphoma, Large B-Cell, Diffuse - Pathology
(4)
Mice
(4)
Signal Transduction
(4)
Tumors
(4)
Biomarkers
(3)
Care And Treatment
(3)
Casein Kinase Ii - Antagonists & Inhibitors
(3)
Casein Kinase Ii - Genetics
(3)
Cell Biology
(3)
Clinical Medicine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(7)
Hemasphere
(3)
Plos One
(3)
Frontiers In Immunology
(2)
Journal Of Clinical Oncology
(2)
Journal Of Pediatric Gastroenterology And Nutrition
(2)
Bmc Cancer
(1)
Cancers
(1)
Current Cancer Drug Targets
(1)
Diagnostics
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells

CK2β-regulated signaling controls B cell differentiation and function

CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death

Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth

CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis

T028: Single‐cell RNA sequencing reveals the interplay between circulating CD4 T cells, B cells and cancer‐associated monocytes in classic Hodgkin lymphoma treated with PD‐1 blockade

Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL

MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8

MYD88 L265P Augments Proximal B-Cell Receptor Signaling in Large B-Cell Lymphomas Via an Interaction with DOCK8

Genetic Perturbation of CD70/CD27 Co-Stimulation Promotes the Development of Bcl6-Driven Diffuse Large B-Cell Lymphoma

Targeted Inhibition of PI3K α/δ Is Synergistic with BCL-2 Blockade in Genetically Defined Subtypes of DLBCL

TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence

CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis

Csnk2β Knockout during Hematopoiesis Results in Lethality at Mid/Late Gestation Mostly Due to Impaired Fetal Erythropoiesis

Csnk2β, the Regulatory Subunit of Protein Kinase CK2, modulates Peripheral B Cell Development Repressing Notch2 Signaling and Promoting a Proper B-Cell Receptor Signal Transmission

Protein Kinase CK2 Inhibition Down Modulates the NF-[kappa]B and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells

Protein kinase CK2 regulates peripheral B cell development

Protein Kinase CK2 Inhibition Down Modulates the NF- Kappa B and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells: e75280

Perceived social support and quality of life in endometrial cancer patients: a longitudinal study

Cerebellar metastasis of ovarian cancer: a case report

Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review

Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation

Liver Involvement in Congenital Disorders of Glycosylation

Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature

Suchergebnisse filtern